Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Kylonova (xiamen) Biopharma Co., Ltd., explained in plain language.
This early-stage study tests a new drug called Kylo-12 in 50 healthy volunteers to see if it is safe and how the body processes it. The drug aims to lower high triglycerides, a type of fat in the blood linked to heart problems. Participants receive either a single shot of Kylo-12…
Phase: PHASE1 • Sponsor: Kylonova (Xiamen) Biopharma co., LTD. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC